Clinical trials in primary hepatocellular carcinoma: current status and future directions
- 1 March 1988
- journal article
- review article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 15 (1) , 1-31
- https://doi.org/10.1016/0305-7372(88)90007-2
Abstract
No abstract availableThis publication has 110 references indexed in Scilit:
- Clinical evaluation of arterial administration of SMANCS in oily contrast medium for liver cancer.Japanese Journal of Medicine, 1985
- Hepatic artery ligation and chemotherapeutic infusion in the treatment of hepatic malignancyJournal of Surgical Oncology, 1984
- Studies on anticancer treatment with an oily anticancer drug injected into the ligated feeding hepatic artery for liver cancerCancer, 1983
- Effect of arterial administration of high-molecular-weight anticancer agent SMANCS with lipid lymphographic agent on hepatoma: a preliminary reportEuropean Journal of Cancer and Clinical Oncology, 1983
- Ligation and catheterization of the hepatic artery for palliative treatment of malignant hepatic tumorsJournal of Surgical Oncology, 1983
- Phase II study of oral VP-16-213 in hepatocellular carcinomaEuropean Journal of Cancer and Clinical Oncology, 1981
- Prolonged and continuous percutaneous intra-arterial hepatic infusion chemotherapy in advanced metastatic liver adenocarcinoma from colorectal primaryCancer, 1979
- INDUCTION OF REMISSION IN HEPATOCELLULAR CARCINOMA WITH DOXORUBICINThe Lancet, 1978
- Complications of long term transbrachial hepatic arterial infusion chemotherapyAmerican Journal of Roentgenology, 1977
- Intrahepatic arterial infusion with 5-fluorouracilCancer, 1971